Argent and AusCann enter strategic partnership
Argent BioPharma and AusCann Group join forces through a new strategic agreement to advance cannabinoid-based pharmaceutical development.
Argent BioPharma and AusCann Group join forces through a new strategic agreement to advance cannabinoid-based pharmaceutical development.
American Salars has been pushing out into several Tier-1 jurisdictions across the globe, searching for more lithium discoveries.
Guy Le Page looks at Somerset Minerals and its untapped upside as it turns toward exploration season over a high-grade copper opportunity.
Good morning! Here’s everything you need to know, and some things you don’t, before the ASX flings open its doors and begins trading today.
With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be next.
The annual resources calendar turns to Canada this weekend for one of the world’s biggest and most influential mining conferences.
American Salars Lithium is acquiring the Leduc East project in Quebec that has 35 known pegmatites and historical feldspar and mica production.
CSE-listed battery metals explorer American Salars Lithium has spread its wings with the acquisition of the LCT pegmatite rich Jaguaribe project in northern Brazil.
Aroa has achieved a key milestone with seven million of its soft tissue regeneration products used in medical procedures
Trump’s chaos is stirring up market volatility, and AEF’s John Woods sees it as a chance to grab bargains.
Singapore family offices and hedge funds along with Hong Kong institutions are bullish on the ASX healthcare sector.
The ASX dumped again on Friday as tariff fears hit BHP and Rio. Meanwhile casino operator Star’s financial crisis deepened.
Original URL: https://www.couriermail.com.au/business/stockhead/page/197